Simulations Plus, Inc. (NASDAQ:SLP) Shares Bought by BNP Paribas Financial Markets

BNP Paribas Financial Markets lifted its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 402.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,944 shares of the technology company’s stock after acquiring an additional 32,002 shares during the quarter. BNP Paribas Financial Markets’ holdings in Simulations Plus were worth $1,279,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Horizon Advisors Inc. raised its stake in shares of Simulations Plus by 82.6% in the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock worth $26,000 after buying an additional 370 shares in the last quarter. nVerses Capital LLC raised its position in Simulations Plus by 1,100.0% in the third quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock worth $38,000 after acquiring an additional 1,100 shares in the last quarter. Quantbot Technologies LP acquired a new stake in Simulations Plus in the 3rd quarter valued at about $59,000. US Bancorp DE boosted its position in shares of Simulations Plus by 37.0% during the 3rd quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock valued at $159,000 after purchasing an additional 1,343 shares in the last quarter. Finally, Los Angeles Capital Management LLC acquired a new position in shares of Simulations Plus in the 2nd quarter worth approximately $206,000. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Up 0.9 %

SLP opened at $30.40 on Tuesday. The firm has a market capitalization of $610.13 million, a P/E ratio of 62.04 and a beta of 0.76. The stock has a fifty day moving average of $30.76 and a 200-day moving average of $36.76. Simulations Plus, Inc. has a 12-month low of $27.07 and a 12-month high of $51.22.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The firm had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. During the same period in the prior year, the business earned $0.18 EPS. The business’s revenue for the quarter was up 19.9% on a year-over-year basis. On average, analysts expect that Simulations Plus, Inc. will post 1.1 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Friday, November 1st. The shares were sold at an average price of $27.66, for a total value of $553,200.00. Following the completion of the sale, the director now owns 3,462,584 shares in the company, valued at $95,775,073.44. This represents a 0.57 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last three months, insiders sold 60,750 shares of company stock worth $1,837,255. 20.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts recently commented on the stock. BTIG Research cut their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. Stephens assumed coverage on Simulations Plus in a research note on Friday, November 15th. They set an “overweight” rating and a $39.00 price objective for the company. StockNews.com lowered Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. Finally, William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $51.40.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.